{"brief_title": "This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.", "brief_summary": "The purpose of this study is to compare the efficacy of ZD6474 and ZD1839 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.", "condition": ["Carcinoma, Non-Small-Cell Lung"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["ZD6474", "Placebo", "ZD1839"], "criteria": "Inclusion Criteria: - Failure of either first-line and/or second-line chemotherapy either of which was platinum-based (the prior regimen must have failed the subject because of toxicity or progression of tumor - Prior histologic or cytologic confirmation of locally advanced or metastatic (IIIB/IV) NSCLC Exclusion Criteria: - Subjects who have received second-line or subsequent chemotherapy - Any evidence of clinically active interstitial lung disease (patients with chronic, stable, radiographic changes who are asymptomatic, need not be excluded)", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "second-line", "mesh_term": ["Carcinoma, Non-Small-Cell Lung", "Gefitinib"], "id": "NCT00059722"}